Sarah Heming

Sarah Heming

VP of Strategic Marketing at Diaceutics | Brand Strategy

Sarah Heming is Interim VP of Strategic Marketing at Diaceutics, where she leads brand strategy and global marketing to help pharma and biotech partners bring diagnostic-driven therapies to more eligible patients. A senior marketing and communications leader with more than two decades across Fortune 500 and highly regulated industries, she has driven transformative growth, award-winning product launches and high-impact corporate rebrands. Sarah previously held marketing leadership roles at Zoetis, Mölnlycke Health Care and Abbott, bringing deep expertise in brand building, stakeholder engagement and omnichannel strategy.

Connect
Resources written by Sarah Heming :
Content that Connects: How to work with KOLs to Build HCPs Trust and Influence

Enhance HCP engagement through peer-led content that builds trust and drives prescribing confidence with Diaceutics' innovative strategies and insights.

By Sarah Heming
hcp_engagement_activation
Diagnostic Pathway Variation: Why Delivery Breaks Before Discovery

Discover how to improve access to diagnostic-driven therapies by addressing delivery challenges and enhancing engagement through real-world insights and targeted solutions.

By Sarah Heming
commercial_strategy_optimisation
Amplifying Your Precision Medicine Strategy: The role of Engagement Experts and Peer Networks

Enhance your precision medicine strategy through multi-modal communications and peer engagement, driving effective diagnostic commercialization and maximizing patient outcomes.

By Sarah Heming
hcp_engagement_activation
Measuring What Matters: How to Track and Improve HCP Engagement ROI

Discover how to effectively measure HCP engagement ROI, linking marketing efforts to clinical outcomes and improving patient care with innovative strategies and insights.

By Sarah Heming
hcp_engagement_activation
ASCO 2026 Trends to Watch: Precision Oncology, AI and Real-World Impact

Explore key trends in precision oncology, AI integration, and real-world impact at ASCO 2026, focusing on biomarker-driven therapies and actionable insights for improved patient outcomes.

By Sarah Heming
data_ai
Q&A: How can a multi-modal approach using lab data simplify precision medicine?

Explore how a multi-modal approach using lab data enhances precision medicine, improving patient outcomes and treatment strategies through actionable insights and better-informed decisions.

By Sarah Heming
data_ai
HCP Engagement Strategies: 4 Takeaways from Fierce Pharma 2026

Discover key insights from Fierce Pharma Engage 2026 on evolving HCP engagement strategies, emphasizing AI, content relevance, and outcome-based performance measurement for impactful interactions.

By Sarah Heming
hcp_engagement_activation
The Clinical Decision Making Window: How Timing Determines Therapy Uptake

Discover how timing influences therapy uptake in diagnostic-driven treatments and learn how targeted engagement can enhance patient outcomes within the clinical decision-making window.

By Sarah Heming
hcp_engagement_activation
ASCO 2026 Day 3 Highlights: A Transformative Advance in Pancreatic Cancer

Discover groundbreaking advancements in cancer treatment from ASCO 2026, including RAS-targeted therapy for pancreatic cancer and novel approaches for prostate and lung cancers.

By Sarah Heming
practice_gaps_publications
Speed to Market Starts Before the Prescription

Discover how Diaceutics and DeepIntent revolutionize pharma marketing by shifting focus to real-time diagnostic intelligence, enhancing engagement before prescriptions are written.

By Sarah Heming
hcp_engagement_activation
The New Edge in Pharma: Smarter Physician Activation for Complex Therapies

Enhance physician engagement with smarter data solutions from Diaceutics, driving timely activation for complex therapies and improving patient treatment outcomes.

By Sarah Heming
hcp_engagement_activation
Navigating Precision Medicine Challenges in IMIDs

Explore the challenges of diagnosing and treating immune-mediated inflammatory diseases, and discover how precision medicine can improve patient outcomes and streamline treatment strategies.

By Sarah Heming
practice_gaps_publications
What Physicians Need Now: Relevance, Timing and Trust

Physicians need timely, relevant, and trusted information to enhance patient care. Discover solutions that empower informed decision-making in a complex healthcare landscape.

By Sarah Heming
hcp_engagement_activation
Seamless Diagnostic Testing: 12 Recommendations to Drive Your Launch Strategy to Success

Explore key barriers to seamless diagnostic testing in precision medicine and discover strategies to enhance patient identification and treatment outcomes.

By Sarah Heming
commercial_strategy_optimisation
Embracing Precision Medicine: The Heart of Value-Based Care

Discover how Diaceutics advances value-based care through precision medicine, ensuring patients receive tailored treatments supported by robust data integration and innovative solutions.

By Sarah Heming
commercial_strategy_optimisation
Unleashing the Potential of the Microbiome in Precision Medicine: A New Frontier for Pharma

Explore how the microbiome is transforming precision medicine, enhancing drug efficacy, and paving the way for innovative therapies in the pharmaceutical industry.

By Sarah Heming
practice_gaps_publications
Reigniting Momentum: A Curated Round‑Up of This Season’s Most Impactful Insights

Discover how real-time diagnostic insights and expert-led engagement can rebuild prescriber confidence and reignite brand momentum.

By Sarah Heming
commercial_strategy_optimisation

Newsletter sign up

Sign up to our bi-weekly newsletter covering the latest insights to optimize commercialization of diagnostic driven therapies to help empower your decisions.

READY TO DO COMMERCIALIZATION DIFFERENTLY?

Every patient journey contains opportunities to improve testing, engagement, and adoption. We can help you find them so more people get the right therapy sooner.